Expression of concern-Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

被引：0
|
作者：
机构：
[1] The Lancet, London NW1 7BY, England
来源：
LANCET | 2013年 / 381卷 / 9873期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1167 / 1167
页数：1
相关论文
共 50 条
  • [21] Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial
    Chiswick, Carolyn
    Reynolds, Rebecca M.
    Denison, Fiona
    Drake, Amanda J.
    Forbes, Shareen
    Newby, David E.
    Walker, Brian R.
    Quenby, Siobhan
    Wray, Susan
    Weeks, Andrew
    Lashen, Hany
    Rodriguez, Aryelly
    Murray, Gordon
    Whyte, Sonia
    Norman, Jane E.
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (10): : 778 - 786
  • [22] Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial
    Siebenhaar, F.
    Foertsch, A.
    Krause, K.
    Weller, K.
    Metz, M.
    Magerl, M.
    Martus, P.
    Church, M. K.
    Maurer, M.
    ALLERGY, 2013, 68 (07) : 949 - 952
  • [23] Effect of a multivitamin and mineral supplement on infection and quality of life - A randomized, double-blind, placebo-controlled trial
    Barringer, TA
    Kirk, JK
    Santaniello, AC
    Foley, KL
    Michielutte, R
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (05) : 365 - 371
  • [24] Rupatadine treatment improves quality of life in patients with mastocytosis: a randomized, double-blind, placebo-controlled trial
    Siebenhaar, F.
    Foertsch, A.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E12 - E12
  • [25] EFFECT OF FENFLURAMINE ON MOOD - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    LICHTENBERG, P
    SHAPIRA, B
    BLACKER, M
    GROPP, C
    CALEV, A
    LERER, B
    BIOLOGICAL PSYCHIATRY, 1992, 31 (04) : 351 - 356
  • [26] Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
    Gibson, Peter G.
    Yang, Ian A.
    Upham, John W.
    Reynolds, Paul N.
    Hodge, Sandra
    James, Alan L.
    Jenkins, Christine
    Peters, Matthew J.
    Marks, Guy B.
    Baraket, Melissa
    Powell, Heather
    Taylor, Steven L.
    Leong, Lex E. X.
    Rogers, Geraint B.
    Simpson, Jodie L.
    LANCET, 2017, 390 (10095): : 659 - 668
  • [27] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MAXEPA IN STROKE PATIENTS
    GREEN, D
    BARRERAS, LR
    BORENSZTAJN, J
    REDDY, N
    ROVNER, R
    SIMON, H
    CLINICAL RESEARCH, 1984, 32 (02): : A309 - A309
  • [28] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUOXETINE IN PATIENTS WITH FIBROMYALGIA
    WOLFE, F
    CATHEY, MA
    HAWLEY, DJ
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S220 - S220
  • [29] A double-blind, placebo-controlled trial of oxandrolone in inclusion body myositis
    Rutkove, SB
    Parker, RA
    Nardin, RA
    Connolly, CE
    Felice, KJ
    Raynor, EM
    NEUROLOGY, 2001, 56 (08) : A464 - A464
  • [30] Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
    McCarey, DW
    McInnes, LB
    Madhok, R
    Hampson, R
    Scherbakova, O
    Ford, I
    Capell, HA
    Sattar, N
    LANCET, 2004, 363 (9426): : 2015 - 2021
12345